Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Caligan Partners LP (CIK 1727492) reported $1.50B across 21 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: LQDA ($306.4M, 20.39%), RVMD ($183.0M, 12.18%), ABVX ($162.8M, 10.83%), PCVX ($119.7M, 7.97%), XENE ($81.0M, 5.39%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LQDA | LIQUIDIA CORPORATION | $306.4M | 20.39% | 8.1M | Hold |
| 2 | RVMD | REVOLUTION MEDICINES INC | $183.0M | 12.18% | 1.9M | Added |
| 3 | ABVX | ABIVAX SA | $162.8M | 10.83% | 1.5M | Added |
| 4 | PCVX | VAXCYTE INC | $119.7M | 7.97% | 2.1M | Added |
| 5 | XENE | XENON PHARMACEUTICALS INC | $81.0M | 5.39% | 1.4M | Added |
| 6 | MLYS | MINERALYS THERAPEUTICS INC | $75.1M | 5.00% | 2.8M | Trimmed |
| 7 | EXEL | EXELIXIS INC | $66.6M | 4.43% | 1.6M | Hold |
| 8 | CGON | CG ONCOLOGY INC | $60.9M | 4.05% | 900,000 | New |
| 9 | TNGX | TANGO THERAPEUTICS INC | $50.4M | 3.35% | 2.4M | Trimmed |
| 10 | TYRA | TYRA BIOSCIENCES INC | $48.9M | 3.25% | 1.3M | Added |
| 11 | ADMA | ADMA BIOLOGICS INC | $45.6M | 3.03% | 5.1M | Added |
| 12 | SYRE | SPYRE THERAPEUTICS INC | $44.3M | 2.95% | 878,127 | New |
| 13 | LB PHARMACEUTICALS INC | $34.6M | 2.30% | 1.4M | New | |
| 14 | VOR | VOR BIOPHARMA INC | $34.3M | 2.29% | 1.9M | Added |
| 15 | SABS | SAB BIOTHERAPEUTICS INC | $30.5M | 2.03% | 8.0M | New |
| 16 | IVA | INVENTIVA SA | $27.6M | 1.84% | 5.0M | Added |
| 17 | IRD | OPUS GENETICS INC | $27.6M | 1.84% | 6.1M | New |
| 18 | MBX | MBX BIOSCIENCES INC | $25.3M | 1.69% | 848,590 | New |
| 19 | AVTX | AVALO THERAPEUTICS INC | $24.4M | 1.62% | 1.6M | Added |
| 20 | ANIK | ANIKA THERAPEUTICS INC | $20.8M | 1.38% | 1.4M | Hold |
| 21 | MAZE | MAZE THERAPEUTICS INC | $18.4M | 1.22% | 614,962 | Added |
| 22 | VRCA | VERRICA PHARMACEUTICALS INC | $4.9M | 0.33% | 923,910 | Hold |
| 23 | SNSE | SENSEI BIOTHERAPEUTICS INC | $4.0M | 0.26% | 126,002 | New |
| 24 | AGIO | AGIOS PHARMACEUTICALS INC | $3.0M | 0.20% | 90,000 | Hold |
| 25 | AURA | AURA BIOSCIENCES INC | $1.5M | 0.10% | 229,864 | New |
Source: SEC Form 13F filings · as of 2026-03-31